PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
PVCT.WS was delisted on the 13th of October, 2016.
2 hedge funds and large institutions have $856K invested in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
29% less capital invested
Capital invested by funds: $1.21M → $856K (-$358K)
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$150K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$446K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$164K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$124K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $686K | – | – | – |
|
|
2
Millennium Management
New York
| $170K | +$150K | +500,000 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$446K | -2,043,405 | Closed |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| – | -$164K | -749,337 | Closed |
|
|
5
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$124K | -577,066 | Closed |
|
PVCT.WS Hedge Fund Activity: Q3 2015 in Review
2 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) for Q3 2015, worth a combined $856K — down 29% from $1.21M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PVCT.WS and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $150K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $446K sold.
- 2 institutional investors held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) as of Q3 2015, down from 4 in Q2 2015.
- Funds reported $856K of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) stock for Q3 2015, down 29% quarter-over-quarter.
- 1 fund opened new PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) positions in Q3 2015 and 3 closed out, a net change of -2 holders.
- The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) buyer in Q3 2015 was Millennium Management, an estimated $150K added.
- The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) seller in Q3 2015 was Susquehanna International Group, an estimated $446K sold.
Based on aggregated 13F filings for Q3 2015.